Christopher Paquette, Founder and CEO, DeepIntent
Since founding DeepIntent in 2016 on the principle that advertising technology can improve patients’ lives, Chris Paquette has taken it from a two-person startup to a successful growth-stage company that now employs more than 250 people. He has positioned DeepIntent as a leader and innovator in the healthcare advertising space, as well as the larger ad tech industry, all while maintaining a strong company culture. Since the company saw its biggest increase in headcount during the pandemic, Chris supported the launch of several initiatives focused on employee culture and recognition over the last year, including an Employee Appreciation Day in March, and an Employee Impact Week that took place in September, complete with its own awards program. In 2022, the company also implemented a new annual review process that is bidirectional and encourages each employee to identify the areas where they want to grow.
With nine out of the top 10 pharma companies and all the leading healthcare advertising agencies as clients, DeepIntent has always made enhancements to its demand side platform with the unique needs of healthcare marketers in mind. The company truly emerged as a major player in the programmatic advertising space during the pandemic, leading the charge on pharma’s shift to CTV.
Under Chris’ leadership, DeepIntent continued to make headlines over the last year with several new product launches and innovations. These include the September 2021 launch of DeepIntent’s Audience Marketplace, the industry’s first and only healthcare data marketplace; the May launch of Patient Reach Guarantees, which guarantees the number of verified patients reached programmatically across CTV, display, and digital video; and the September launch of DeepIntent’s Patient Planner, which revolutionizes the way patient campaigns are planned and activated.
Without question, Chris is a rising star in the healthcare advertising industry. He’s a frequent presenter and panelist at major events, sharing his perspective at such conferences as DTC National, ID5’s Identity Summit, and VideoNuze’s CTV Advertising Summit. He gave the keynote address at Digital Pharma East in Philadelphia in 2021, and as a member of the Forbes Tech Council, has written several bylines over the last year about the convergence of health data and digital health marketing and the role of AI and machine learning in healthcare advertising. He’s also a member of the IAB Tech Lab and serves as an advisor for Memorial Sloan Kettering as the research institution begins to develop its own machine learning strategies to improve the patient journey toward wellness.
